Connext (Drug Discovery) is Drug Discovery in South Korea that focus on bio-venture intended business. Founded in 2017. They cover business area such as operator, clinical-stage bio-venture, treatment, rare disease, radiation-induce disease, recombinant collagenase, musculoskeletal disease, doctor, indication, oncology, dermatology, opportunity, partner.
2017
( 7 years old in 2024 )
Bio-venture Intended
-
322 Teheran-ro
Seoul, Gangnam-gu
South Korea
Private
operatorclinical-stage bio-venturetreatmentrare diseaseradiation-induce diseaserecombinant collagenasemusculoskeletal diseasedoctorindicationoncologydermatologyopportunitypartner
* We use standard office opening hours in near Connext (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Connext (Drug Discovery) is Drug Discovery business from South Korea that founded in 2017 (7 years old in 2024), Connext (Drug Discovery) business is focusing on Bio-venture Intended.
Connext (Drug Discovery) headquarter office and corporate office address is located in 322 Teheran-ro Seoul, Gangnam-gu South Korea.
Connext (Drug Discovery) was founded in South Korea.
In 2024, Connext (Drug Discovery) is currently focus on bio-venture intended sector.
Above is snippet of Google Trends for "bio-venture intended" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Connext (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
